Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction
Left ventricular systolic dysfunction (LVSD) defined by ejection fraction (EF) <40% is common, serious but treatable, and correct diagnosis is the cornerstone of effective treatment. Biomarkers may help to diagnose LVSD and give insight into the pathophysiology. The immune system is activated in...
Saved in:
Main Authors: | Line Lisbeth Olesen, Thomas Vauvert F. Hviid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/8417190 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A Review
by: Lasse Lindholm Johansen, et al.
Published: (2016-01-01) -
Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction
by: M. V. Fadeeva, et al.
Published: (2019-06-01) -
Early Left Ventricular Systolic and Diastolic Dysfunction in Patients with Newly Diagnosed Obstructive Sleep Apnoea and Normal Left Ventricular Ejection Fraction
by: Lisulov Popovic Danica, et al.
Published: (2014-01-01) -
Diagnostic Value of High-Sensitivity Troponin T for Subclinical Left Ventricular Systolic Dysfunction in Patients with Sepsis
by: Pham Dang Hai, et al.
Published: (2021-01-01) -
Comparative Value of Simple Inflammatory Markers in the Prediction of Left Ventricular Systolic Dysfunction in Postacute Coronary Syndrome Patients
by: Panagiotis Aggelopoulos, et al.
Published: (2009-01-01)